首页> 外文期刊>Cancer immunology research. >Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
【24h】

Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells

机译:肿瘤相关的巨噬细胞通过DNA甲基转移酶1在胃癌细胞中促进凝席蛋白的表观遗传沉默

获取原文
获取原文并翻译 | 示例
           

摘要

Epigenetic repression of the tumor suppressor gelsolin (GSN) is frequently observed in cancers. Chronic inflammation can promote tumor progression via aberrant DNA methylation. In this study, we investigated the role of tumor-associated macrophages (TAMs) inDNAmethylation of theGSNgene during gastric cancer progression. Immunofluorescence staining of 121 gastric cancer tissues showed aberrant localization of GSN and DNA methyltransferase 1 (DNMT1) and juxtaposition of DNMT1 and M2 TAMs. Decreased GSN protein and mRNA expression and increased DNA methylation in the GSN promoter were observed in gastric cancer cell lines and clinical specimens. To examine the effect of TAMs on DNA methylation in gastric cancer cells, we performed in vitro coculture assays and found increased DNMT1 expression but decreased GSN expression in gastric cancer cells after coculture with U937 cells. Knockdown of DNMT1 expression in gastric cancer cells could abort U937 coculture-mediated GSN downregulation. Meanwhile, CCL5 was the main chemokine upregulated in coculture medium. Treatment with CCL5 could induce DNMT1 expression in gastric cancer cells via STAT3 signaling. Inhibiting DNMT1 activity with procainamide, inhibiting DNA methylation with 5-AZA, or inhibiting CCL5/CCR5 signaling with maraviroc reduced tumor growth in vivo. In conclusion, upregulation of DNMT1 by CCL5/CCR5/STAT3 signaling is critical for TAM-mediated GSN silencing in gastric cancer. This study identified potential targets for gastric cancer therapy. (C) 2017 AACR.
机译:在癌症中经常观察到肿瘤抑制凝溶胶蛋白(GSN)的表观遗传抑制。慢性炎症可以通过异常DNA甲基化促进肿瘤进展。在这项研究中,我们调查了肿瘤相关巨噬细胞(TAMS)鼻内甲烯在胃癌进展过程中的作用。 121个胃癌组织的免疫荧光染色表现出GSN和DNA甲基转移酶1(DNMT1)的异常定位,以及DNMT1和M2 TAM的并置。在胃癌细胞系和临床标本中观察到GSN蛋白和mRNA表达减少并增加了GSN启动子中的DNA甲基化。为了检查TAMS对胃癌细胞中DNA甲基化的影响,我们在体外共培养测定中进行,发现DNMT1表达增加,但与U937细胞共培养后胃癌细胞中的GSN表达降低。胃癌细胞中DNMT1表达的敲低可以中止U937共培养介导的GSN下调。同时,CCL5是在共培养基中上调的主要趋化因子。用CCL5处理可以通过STAT3信号传导诱导胃癌细胞中的DNMT1表达。抑制丙因胺的DNMT1活性,抑制用5-AZA的DNA甲基化,或抑制具有Maraviroc的CCl5 / CCR5信号传导,减少体内肿瘤生长。总之,CCL5 / CCR5 / STAT3信号传导对DNMT1的上调对于胃癌中的TAM介导的GSN沉默至关重要。本研究确定了胃癌疗法的潜在目标。 (c)2017年AACR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号